These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Dopaminergic involvement in the improving effects of dynorphin A-(1-13) on scopolamine-induced impairment of alternation performance.
    Author: Itoh J, Ukai M, Kameyama T.
    Journal: Eur J Pharmacol; 1993 Sep 07; 241(1):99-104. PubMed ID: 7901037.
    Abstract:
    The present study was designed to clarify whether dopamine systems are involved in the effect of dynorphin A-(1-13), an endogenous kappa-opioid receptor agonist, on the scopolamine-induced impairment of spontaneous alternation performance related to working memory in mice. Sulpiride (10 and/or 30 mg/kg), a dopamine D2-selective antagonist, markedly improved the impairment of alternation performance and significantly reduced the increase in total arm entries (i.e. locomotor activity) induced by scopolamine (1 mg/kg). In contrast, SCH 23390 (0.01, 0.03 and 0.1 mg/kg), a dopamine D1-selective antagonist, did not influence the impairment of alternation performance, whereas it dose dependently reduced total arm entries in scopolamine-treated mice RU 24213 (1 mg/kg), a dopamine D2-selective agonist, almost completely reversed the improving effect of dynorphin A-(1-13) (3 micrograms) on the scopolamine-induced impairment of alternation performance and reduced total arm entries, although it was without effects on behavioral responses in normal mice. However, SKF 38393 (3 and 10 mg/kg), a dopamine D1-selective agonist, failed to change alternation performance or total arm entries in normal or scopolamine-treated mice. These findings suggest that the impairment of spontaneous alternation performance induced by scopolamine is improved by the blockade of dopamine D2 receptors. Furthermore, the improving effect of dynorphin A-(1-13) on the scopolamine-induced impairment of spontaneous alternation performance may be based upon the inhibition of dopaminergic activity through the mediation of kappa-opioid receptors.
    [Abstract] [Full Text] [Related] [New Search]